Measuring total corneal power before and after laser in situ keratomileusis with high-speed optical coherence tomography
Accepted 6 April 2006.
Purpose
To measure total corneal power using optical coherence tomography (OCT).
Setting
Refractive surgery practices at 2 academic eye centers in Cleveland, Ohio, and Los Angeles, California, USA.
Methods
Thirty-two eyes of 17 patients having myopic laser in situ keratomileusis (LASIK) were enrolled in a prospective observational study. Manifest refraction, OCT, and Placido ring corneal topography with the Atlas 995 (Carl Zeiss Meditec, Inc.) were performed preoperatively and 3 months after laser in situ keratomileusis (LASIK). A high-speed (2000 axial scans/second) corneal and anterior segment OCT prototype was used. The total corneal power was calculated by summation of the anterior and posterior surface powers, and the value was compared with that determined by simulated keratometry. Two methods of measuring total corneal power were tested: the direct method, which used OCT to measure both corneal surfaces directly, and the hybrid method, which combined OCT with anterior corneal topography.
Results
The repeatability (pooled standard deviation) of measuring total corneal power using the hybrid method was 3 times better than that using the direct method. It was 0.23 diopter (D) before LASIK and 0.26 D after LASIK. Preoperative total power was 1.13 D (2.6%) lower than the simulated keratometry. Compared to the LASIK-induced change in spherical equivalent refraction, the change in total corneal power was equivalent, while the change in simulated keratometry power was significantly smaller (−18.8%) (P<.001).
Conclusions
Keratometry using the traditional index of 1.3375 overestimated the total power in preoperative corneas and underestimated LASIK-induced refractive change. Measuring both corneal surfaces using a combination of OCT and Placido ring topography provided a better measure of total corneal power that closely tracked the refractive change in post-LASIK eyes.
From the Doheny Eye Institute and Department of Ophthalmology, University of Southern California, Los Angeles, California, USA
Corresponding author: David Huang, MD, PhD, 1450 San Pablo Street, DEI 5702, Los Angeles, California 90033, USA.
Drs. Huang and Tang receive grant support from Carl Zeiss Meditec, Inc. Dr. Huang receives patent royalties related to optical coherence tomography technology. Drs. Li and Avila have no financial or proprietary interest in any material or method mentioned.
Supported by grants from NIH (R01 EY013516 and P30 EY03040), Carl Zeiss Meditec, Inc., and Research to Prevent Blindness, Inc.
ABSTRACT